HamidRezaMirshahidiMD

PubMed

• 40 citations
  A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade ...
  Sylvia Adams, Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh
  Clinical Cancer Research. 2021-10-29
• 57 citations
  Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes.
  David A. Bush, Sharon Do, Sharon S. Lum, Carlos A. Garberoglio, Hamid R. Mirshahidi
  International Journal of Radiation Oncology, Biology, Physics. 2014-11-01
• 22 citations
  Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics.
  Zeina Nahleh, Salman Otoukesh, Hamid R. Mirshahidi, Anthony L. Nguyen, Gayathri Nagaraj
  Cancer Medicine. 2018-06-01

Journal Articles

• Nivolumab-induced pericardial effusion  
  Sheehen S, Mirshahidi HR, Nagaraj G, Hsueh CT, Lung Cancer. Exp Hematol Oncol, 1/1/2018
• Metastatic Biomarkers In Synovial Sarcoma  
  Necochea-Campion RD, Zuckerman LM; Mirshahidi HR, Khosrowpour S, Chen CS, Mirshahidi S, Biomarker Research, 1/7/2017
• SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete res...  
  Nahleh ZA, Barlow WE, Hayes DF, Schott AF, Gralow JR, Sikov WM, Perez EA, Chennuru S, Mirshahidi HR, Corso SW, Lew DL, Pusztai L, Livingston RB, Hortobagyi GN, Breast Cancer Res Treat., 1/1/2016
•  
  Raza A, Cao H, Conrad R, Cobb C, Castelino-Prabhu S, Mirshahidi S, Shiraz P, Mirshahidi HR, Expert Review of Anticancer Therapy., 1/1/2015
• Efficacy of crizotinib inhibiting specific molecular pathways in non-small-cell lung carcinoma  
  Mirshahidi HR, Mirshahidi S., Expert Rev Anticancer Ther, 1/1/2015
• Partial Breast Radiation Therapy with Proton Beam: 5-Year Results with Cosmetic Outcomes  
  Bush DA, Do S, Lum S, Mirshahidi H, Patyal B, Grover R, Slater JD., Int J Radiat Oncol Biol Phys, 1/30/2014
• A Novel Insertion Mutation at Exon 20 of EGFR Conferring Resistance to Erlotinib  
  Khan NA, Mirshahidi S, Mirshahidi HR., Case Rep Oncol, 1/6/2014
• A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuz...  
  Hurvitz SA, Dalenc F, Campone M, O�Regan R, Tjan-Heijnen VC, Gligorov J, Llombart A, Jhangiani H, Mirshahidi HR, Tan-Chiu E, Sahmoud T, Sara Miao S, El-Hashimy M, Linc..., Breast Cancer Res Treat, 1/8/2013
• Can Eribulin Change Treatment algorithm in Management of Breast Cancer?  
  Mirshahidi HR, Mirshahidi S, Abraham J, Future Medicine, Breast Cancer Management, 1/1/2013
• Highdose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year e...  
  Bush DA, Cheek G, Zaheer S, Wallen J, Mirshahidi H, Katerelos A, Grover R, Slater JD, Int J Radiat Oncol Biol Phys, 1/1/2013
• Suicide in Cancer Patients in California, 1997�2006  
  Nasseri K , Mills P , Mirshahidi HR, Moulton LH, Archives of Suicide Research, 1/1/2012
• Promising data, but challenges remain in selecting appropriate TKIs  
  Mirshahidi HR, Community Oncology, 1/1/2011
• Use of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Management of Patients and Practical Applications for Pharmacy Practitioners  
  Wong SF, Mirshahidi HR, The Annals of Pharmacotherapy., 1/1/2011
• Novel targeted therapeutics: Inhibitors of ALK, PARP, And MDM2  
  Mirshahidi HR, Yuan Y, Hsueh CT, JHO, 1/1/2011
• Updates in Non-Small Cell Lung Cancer � Insights from the 2009, 45th Annual Meeting of The American Society of Clinical Oncology  
  Mirshahidi HR, Hsueh CT, J Hematol Oncol, 1/2/2010
• Zoledronic acid improves disease-free survival in hormone-responsive early breast cancer Adding zoledronic acid: a further step to the cure in breast cancer patients  
  Mirshahidi HR, Abraham J, Stenger M, Community Oncology, 1/1/2009
• Genomic Profile in Clinical Oncology  
  Mirshahidi HR, Abraham J., Postgraduate Medicine, 1/1/2006
• Management of early breast cancer  
  Mirshahidi HR, Abraham J., Postgraduate Medicine, 1/1/2004
• Join now to see all

Books/Book Chapters

• Loma Linda University Medical Oncology and Hematology Guideline 
  Mirshahidi HR, Chen CS, Hsueh CT, Yuan Y, Quan W, Mohr G, Hardin S, Montero MLoma Linda University Cancer CenterEdition Seco,2011
• Emerging Cancer Therapeutics for Breast Cancer 
  Abraham J, Mirshahidi H, Hudis CA., Al-Mushawah A, Chowdhury N., Chowdhury ME, EngWong J, Dent R, Goyal S, Grabler P, Haffty BG, Karstaedt PJ, Khan AJ, Loudig OD, Mikh...DemosMedical2010
• Breast Cancer � A Clinical Guide. 
  Abraham J, Kanate AS, Mirza M, Sehbai A, Passage K, McCarthy N, Mirshahidi HR, Cook L, Goldman CD, Pollock J, Asif N, Greenberg DB, Tan AR, Higa G, Price A, Kurian S, ...Wolter Klumer, Lippincott Williams and Wilkins, Philadelphia2006
• The Oncology Knowledge Bank. 
  Parikh PM, Abraham J, Mirshahidi HR, et al.Editors: Dr. Purvish M. Parikh.India2006
• Bethesda Handbook of Clinical Oncology 
  Abraham J, Criag M, Mirshahidi HR, Al-Taha R, Kurian S, Erikson S, et al.Lippincott Williams and WilliamsEdition Seco,2005
• Join now to see all

Abstracts/Posters

• Evidence-based conclusions and inclinations of pemetrexed, taxane and bevacizumab in advanced lung cancer.
  Shaheen S, Ji L, Morgan2JW, Otoukesh S, Mirshahidi HR., Journal of Thoracic Oncology. The 8th European Lung Cancer Congress (ELCC), Geneva, Switzerland, 1/11/2018
• Antiproliferative effect of bupivacaine on patient-derived sarcoma cells.
  Zuckerman LM, Mirshahidi HR, Williams NL, Elsissy J, Shields TG, Otoukesh S, Mirshahidi S., The Connective Tissue Oncology Society., Rome, Italy, 1/1/2018
• EGFR reporting in stage IV adenocarcinoma of the lung: Demographic predictors of EGFR testing and survival.
  Shaheen S, Ji L, Morgan2JW, Otoukesh S, Mirshahidi S, Mirshahidi HR, ASCO, Chicago, 1/1/2018
• Disparities in breast cancer: A multi-institutional comparative analysis focusing on American Hispanics.
  Nahleh Z, Otoukesh S, Dwivedi A, Mirshahidi HR, Nguyen A, Badri N, Botrus G, Diab N, Alvarado A. Sanchez L, San Antonio Breast Cancer Symposium, 1/1/2017
• Less Is More: Video Assisted Thoracic Surgery (VATS) vs Open Thoracotomy in the Management of Resectable Lung Cancer
  Shaheen S, Jabo B, Kaur M, Senthil M, Mirshahidi S, Zaheer S, Mirshahidi HR., The World Lung Cancer Conference, Yokohama, Japan, 1/1/2017
• Outcomes of video assisted thoracic surgery compared with open thoracotomy in patients with early stage Lung cancer.
  Saheen S, Mirshahidi S, Brice J,, Manmeet K, Sethil M, Zaheer S, Mirshahidi HR., ASCO, 1/1/2017
• Amethyst NSCLC Trial: Phase 2, Parallel-Arm Study of Receptor Tyrosine Kinase (RTK) Inhibitor, MGCD265, in Patients (pts) with Advanced or Metastatic NonSmall Cell Lun...
  Igor I. Rybkin, Ebenezer A. Kio, Ashiq Masood, Merrill Kingman Shum, Balazs Halmos, Collin M. Blakely, Keith D. Eaton, Neelesh Sharma, John J. Nemunaitis, Steven J. Sa..., ASCO, J Clin Oncol, Chicago, 1/1/2016
• Acquired Hemophilia A Secondary to Rectal Cancer in Setting of Massive, Uncontrolled Bleeding
  Ratanatharathorn C, Oregel KZ, Mirshahidi H., American College of Physicians Southern California II; Loma Linda, CA, 1/1/2015
• Hortobagyi GNS0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim with or without Bevacizumab in Treating Women with Inflammatory or Locally Advance...
  Nahleh ZA, Barlow WE, Hayes DF, Schott AF, Gralow JR, Perez EA, Sikov WM, Chennuru S, Mirshahidi H, Vidito S, Lew DL, Pusztai L, Livingston RB, SABCS, Cancer Research, AACR, San Antonia Texas, 1/1/2015
• A Randomized Phase 2 Trial of MM-121, a Fully Human Monoclonal Antibody Targeting ErbB3, in Combination with Erlotinib, in EGFR Wild- type NSCLC Patients.
  Sequist, L.V.; Lopez-Chavez, A.; Doebele, R.; Gray, J.; Harb, W.; Modiano, M.; Jackman, D.; Baggstrom, M.; Atmaca, A.; Felip, E.; Provencio, M.; Cobo, M.; Mirshahidi, ..., ASCO, J Clin Oncol, Chicago, 1/1/2014
• The Fateful MRI: A case report of a massive Incidentaloma
  Constance Stoehr, Ather Mehbob, Hamid Mirshahidi., ACP, Loma Linda, CA, 1/1/2014
• NUT Midline Carcinoma With Elevated Alpha-fetoprotein and Synaptophysin Positivity: A Case Report and Review Of The Literature.
  Conrad R; Mirshahidi HR; Cobb C; Castelino-Prabhu S; Raza A, The Pathologists� Meeting (CAP�12), San Diego, 1/1/2012
• Phase I study of azacitidine and cisplatin in patients with advanced head and neck or non-small cell lung cancer.
  LiaoYM, Mirshahidi HR, Kangling Zhang K, Mirshahidi S, Williamson S, Hsueh CT, AACR, Chicago, 1/1/2012
• Comparative effectiveness assessment of a lung cancer multidisciplinary practice to improve patient care.
  Mirshahidi HR, Hernandez E, Ta M, Baylon SM, Pham MT, Lee B, Jahng P, Kung L, Wong SF., ASCO, J Clin Oncol, Chicago, 1/1/2012
• Suicide in Cancer Patients in California, 1997-2006
  Mirshahidi HR, Nasseri K, Mills PK, ASCO, Chicago, 1/1/2011
• A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2- overexpressing advanced breast cancer that progressed during prior trastu...
  Dalenc F, Hurvitz SA, Campone M, O�Regan R, Tjan-Heijnen VC, Gligorov J, Llombart A, Jhangiani H, Mirshahidi HR, Tan-Chiu E, Sahmoud T, Sara Miao S, El-Hashimy M, Linc..., J Clin Oncol, 1/1/2010
• Phase I/II study of AT-101 in combination with topotecan in patients with relapsed or refractory small cell lung cancer after prior platinum containing first line chem...
  Heist RS, Molina JR, Urba WJ, Mirshahidi HR, Grunberg S, Maleski J, Brainerd V, Leopold L, Lynch TJ., J Clin Oncol, 1/20/2008
• Expression of Check-Point kinase CHK2 in human cancers: Preliminary attempt to correlate with tumor sensitivity to DNA damaged based therapy
  Mirshahidi HR., West Virginia University, the Comprehensive Lung Cancer Program, Morgantown, WV, 1/1/2005
• Check-point kinase expression in carcinomas: relation between tumor sensitivity and DNA damage induced by therapy in NSCLC.
  Mirshahidi HR, Rogers J, Tallaksen Szwerc Zhzng P., ASCO 41st Annual Meeting, JCO, 1/1/2005
• Dysfunctional Plasma HDL in patients with coronary atherosclerosis.
  Mirshahidi HR, Navab M., Federation of American Societies for Experimental Biology, Washington, DC, 1/1/1999
• Extyremely delayed osseous pelvic metastasis of Pineoblastoma
  Nguyen AL, Shaheen S, Mirshahidi H, Hsueh CT., California Medical Society House of Delegates� (HOD), American College of Physicians Region II 2016 Southern California Regional Scientific Meeting and Poster Competition, Sacramento, CA.
• Join now to see all

Lectures

• The effect of non-steroidal anti-inflammatory drugs on osteosarcoma cells 
  Loma Linda, CA - 1/1/2019
• Personalized Treatment for Lung Cancer 
  Loma Linda University - 1/1/2011
• Suicide in Cancer Patients with Carcinoma of Lung and Bronchus in California, 1997-2006 
  Amsterdam, Netherland - 1/1/2011
• The oncologist representing Loma Linda University to discuss the various stages of breast cancer treatment and answer questions for newly diagnosed cancer patients, th... 
  Riverside Community Center - 1/26/2010
• Breast Cancer: Now what? The oncologist representing Loma Linda University to discuss the various stages of breast cancer treatment and answer questions for newly diag... 
  Riverside Community Center - 1/15/2010
• Educational lectures For Loma Linda University Medical Center Oncology Nurses 
  1/1/2010
• Advances in Treatment of Non-Small Cell Lung Cancer in 21st Century. 
  1/1/2010
• New Developments in Treatment of Lung Cancer. 
  Loma Linda University - 1/1/2009
• A rare presentation of gastric adenocarcinoma with acute pulmonary embolism and fatal acute disseminated intravascular coagulation. 
  Monterey CA - 1/1/2006
• Check-Point Kinase expression in carcinomas: An attempt to establish the relation between tumor sensitivity and DNA damaged based therapy 
  Tampa, Florida - 1/1/2004
• Secondary angiosarcoma of the breast; Impact of surgical treatment and radiation dose in disease free survival. 
  Beckley, WV - 1/1/2003
• RhoC GTPase modifies the expression of invasion and angiogenesis related genes in breast cancer. 
  Travercity, MI. - 1/1/2001
• RhoC GTPase, transforming oncogenes of mammary epithelium, stimulates expression of genes involved in Cytoskeletal reorganization and motility. 
  New Orleans, LA - 1/1/2001
• Join now to see all

Other

• Factors influencing the incidence of diarrhea in rural areas of the province Of Khorassan, Iran. 
  Mirshahidi HR
  University of Teheran, School of Medicine. Tehran, Iran - 1/1/1993
• Sex education for young adults in Istanbul. 
  Mirshahidi HR.
  School of Medicine, Marmara University. Istanbul, Turkey, - 1/1/1991